Product NDC: | 0115-1911 |
Proprietary Name: | Rimantadine Hydrochloride |
Non Proprietary Name: | Rimantadine Hydrochloride |
Active Ingredient(s): | 100 mg/1 & nbsp; Rimantadine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-1911 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076132 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050401 |
Package NDC: | 0115-1911-02 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0115-1911-02) |
NDC Code | 0115-1911-02 |
Proprietary Name | Rimantadine Hydrochloride |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0115-1911-02) |
Product NDC | 0115-1911 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Rimantadine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20050401 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | RIMANTADINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |